2024 annual financial data
Cogent Biosciences 2024 Operating margin
Cogent Biosciences 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -275,939,000 USD and net income was -255,859,000 USD.
Operating cash flow was -207,791,000 USD.
Get free Cogent Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -275,939,000 USD
- Net income
- -255,859,000 USD
- Operating cash flow
- -207,791,000 USD